Jason Gordon

1.4k total citations
72 papers, 742 citations indexed

About

Jason Gordon is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Jason Gordon has authored 72 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 15 papers in Economics and Econometrics. Recurrent topics in Jason Gordon's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (19 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Jason Gordon is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (19 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Jason Gordon collaborates with scholars based in United Kingdom, United States and Australia. Jason Gordon's co-authors include Phil McEwan, Jorge Puelles, Daniel Sugrue, Iskandar Idris, Nathan R. Hill, Usman Farooqui, Marc Evans, Steven Lister, Hayley Bennett and Yong Yuan and has published in prestigious journals such as PLoS ONE, Diabetes and Annals of the Rheumatic Diseases.

In The Last Decade

Jason Gordon

68 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason Gordon United Kingdom	17	228	171	136	110	73	72	742
Tariq Siddiqui United States	14	88 0.4×	48 0.3×	162 1.2×	30 0.3×	62 0.8×	46	639
Mario Ouwens United Kingdom	17	84 0.4×	32 0.2×	113 0.8×	210 1.9×	49 0.7×	67	904
Markos Kalligeros United States	16	84 0.4×	54 0.3×	352 2.6×	31 0.3×	34 0.5×	49	1.0k
W S A Smellie United Kingdom	16	110 0.5×	138 0.8×	78 0.6×	52 0.5×	31 0.4×	46	851
Yasaman Vali Netherlands	13	133 0.6×	46 0.3×	430 3.2×	63 0.6×	22 0.3×	24	728
Ashish Verma United States	16	134 0.6×	89 0.5×	88 0.6×	21 0.2×	19 0.3×	84	1.0k
Robert C. Hawkins Singapore	15	105 0.5×	59 0.3×	94 0.7×	22 0.2×	28 0.4×	45	1.2k
SJ Pocock United Kingdom	11	217 1.0×	455 2.7×	85 0.6×	134 1.2×	33 0.5×	16	1.0k
Wadie M. Elmadhoun Sudan	15	307 1.3×	90 0.5×	177 1.3×	17 0.2×	26 0.4×	35	594
Ying Zheng China	16	65 0.3×	168 1.0×	141 1.0×	46 0.4×	30 0.4×	70	770

Countries citing papers authored by Jason Gordon

Since Specialization

Citations

This map shows the geographic impact of Jason Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Gordon more than expected).

Fields of papers citing papers by Jason Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Gordon. The network helps show where Jason Gordon may publish in the future.

Co-authorship network of co-authors of Jason Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Gordon. A scholar is included among the top collaborators of Jason Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Gordon. Jason Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhen, Xuemei, Xueshan Sun, Yixi Chen, et al.. (2024). Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model. BMJ Open. 14(8). e086039–e086039. 1 indexed citations

Gordon, Jason, et al.. (2023). Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study. PharmacoEconomics. 42(3). 329–341.

Hill, Nathan R., Sarah Lawton, Daniel Sugrue, et al.. (2022). Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England. Journal of Medical Economics. 25(1). 974–983. 13 indexed citations

Chaudhary, Mohammad A., et al.. (2022). MSR16 Mixture-Cure Modelling of Overall Survival of Patients With Metastatic Non-Small Cell Lung Cancer Receiving Nivolumab + Ipilimumab in CheckMate 277 – Updated With 5 Years of Follow-up. Value in Health. 25(12). S353–S353. 1 indexed citations

Gordon, Jason, et al.. (2021). Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. PharmacoEconomics - Open. 5(4). 701–713. 3 indexed citations

Gordon, Jason, et al.. (2020). Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme. Diabetes Obesity and Metabolism. 22(5). 857–865. 7 indexed citations

Hawkins, Robert D., Kate Fife, Meng Wang, et al.. (2020). Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK. BMC Cancer. 20(1). 670–670. 11 indexed citations

Hill, Nathan R., Daniel Ayoubkhani, Phil McEwan, et al.. (2019). Predicting atrial fibrillation in primary care using machine learning. PLoS ONE. 14(11). e0224582–e0224582. 90 indexed citations

Hill, Nathan R., Jason Gordon, Anna María Geretti, et al.. (2019). Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysis. BMJ Open. 9(8). e029066–e029066. 2 indexed citations

10.

Nour, Nawal M., et al.. (2019). PNS66 NON-INFERIORITY TRIALS IN HEALTH TECHNOLOGY ASSESSMENT - DO THEY NECESSITATE A COST-MINIMISATION APPROACH?. Value in Health. 22. S773–S773. 1 indexed citations

11.

Gordon, Jason, Phil McEwan, Iskandar Idris, Marc Evans, & Jorge Puelles. (2018). Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study. BMJ Open Diabetes Research & Care. 6(1). e000512–e000512. 40 indexed citations

12.

Ayoubkhani, Daniel, Matthew Lumley, Steven Lister, et al.. (2018). Machine Learning to Detect and Diagnose Atrial Fibrillation and Atrial Flutter (AF/F) Using Routine Clinical Data. Value in Health. 21. S213–S213. 1 indexed citations

13.

Tyas, David, et al.. (2017). The Cost-Effectiveness of Nivolumab for The Treatment of People with Relapsed or Refractory Classical Hodgkin Lymphoma Following Autologous Stem Cell Transplant and Brentuximab Vedotin. Value in Health. 20(9). A433–A433. 4 indexed citations

14.

Gordon, Jason, et al.. (2017). Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China. Value in Health. 20(9). A782–A782.

15.

McEwan, Phil, et al.. (2016). Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer. Value in Health. 19(7). A372–A372. 2 indexed citations

16.

Bennett, Hayley, Phil McEwan, Klas Bergenheim, & Jason Gordon. (2014). Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK. Diabetes Therapy. 5(2). 567–578. 9 indexed citations

17.

McEwan, Phil, et al.. (2010). Assessing the Relationship between Computational Speed and Precision. PharmacoEconomics. 28(8). 665–674. 23 indexed citations

18.

Gordon, Jason, et al.. (2010). A comparison of intermediate and long‐acting insulins in people with type 2 diabetes starting insulin: an observational database study. International Journal of Clinical Practice. 64(12). 1609–1618. 30 indexed citations

19.

Sharplin, P, et al.. (2009). Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study. Cardiovascular Diabetology. 8(1). 3–3. 21 indexed citations

20.

Girling, Alan, G. H. Freeman, Jason Gordon, et al.. (2007). Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. International Journal of Technology Assessment in Health Care. 23(2). 269–277. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact